GlassScriptPhysician profile
John Michael Apostolakos
NPI 1306378419
$47,973.90
in general payments reported to CMS, 2019-2025
11 companies · $6,427 in 2025
The $6,427 reported for 2025 was more than what 84% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,528 · 2023: $31K · 2024: $4,182 · 2025: $6,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $20K · Travel and Lodging: $9,185 · Education: $6,469 · Food and Beverage: $5,792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,000.00 |
| Travel and Lodging | $9,185.11 |
| Education | $6,468.75 |
| Food and Beverage | $5,792.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $25,863.11 | 2023-2025 | |
| Smith+Nephew, INC. | $15,490.73 | 2022-2025 | Acufex Meniscal Root Repair, Q-Fix, Healicoil |
| Stryker Corporation | $3,242.64 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform, Salvation |
| Shoulder Innovations, INC. | $1,515.49 | 2024-2025 | Inset System |
| Nexus Medical Technologies LLC | $605.43 | 2024-2025 | |
| Rock Medical Orthopedics, INC. | $579.09 | 2023-2024 | |
| Depuy Synthes Sales INC. | $189.22 | 2023-2024 | Fms, Dynacord, Bristow Latarjet |
| Vericel Corporation | $176.27 | 2022-2025 | Maci |
| Globus Medical, INC. | $140.48 | 2023 | Distal Femur Plate System |
| Orthalign INC | $134.72 | 2024 | Orthalign Plus |
| Ossur Americas, INC. | $36.72 | 2024 | Miami J |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Apostolakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.